Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
cancer therapeutics Market Research Reports
cancer therapeutics Market Research Reports
| Title | published | price | |
|---|---|---|---|
Pediatric Diffuse Intrinsic Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... w of the Pediatric Diffuse Intrinsic Pontine Glioma pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Pediatric Diffuse Intrinsic Pontine Glioma, complete with analysis by Stage o......" | 02-May-2022 | $2000 | |
B-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for B-Cell Leukemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The ......" | 02-May-2022 | $2500 | |
Natural Killer Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ll Lymphomas pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Natural Killer Cell Lymphomas, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA......" | 02-May-2022 | $2000 | |
Acral Lentiginous Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... oma pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Acral Lentiginous Melanoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of ......" | 02-May-2022 | $2000 | |
Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "......
The report provides comprehensive information on the therapeutics under development for Adenocarcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The repo......" | 02-May-2022 | $2000 | |
Adrenal Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... cape.
The report provides comprehensive information on the therapeutics under development for Adrenal Gland Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and......" | 02-May-2022 | $2000 | |
Angioimmunoblastic T-Cell Lymphoma (AITL)-Immunoblastic Lymphadenopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... oA, RoA, Molecule Type and Key Players provides an overview of the Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy pipeline landscape.
The report provides comprehensive information on the therapeutics under develo......" | 02-May-2022 | $2000 | |
Cutaneous T-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Cutaneous T-Cell Lymphoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Admi......" | 02-May-2022 | $2000 | |
Carcinoid Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Carcinoid Tumor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The ......" | 02-May-2022 | $2000 | |
Esophageal Squamous Cell Carcinoma (ESCC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... of the Esophageal Squamous Cell Carcinoma (ESCC) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Esophageal Squamous Cell Carcinoma (ESCC), complete with analysis by Stage of De......" | 02-May-2022 | $2000 | |
| | |||